Bach Mai Hospital is a multi-field medical facility in Hanoi and is considered one of the largest in Vietnam. The hospital was established in 1911 during the French colonial rule.

During the past decade, Bach Mai Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bach Mai Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Euresist Network GEIE" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Neuroscience Trials Australia" with 2 trials sponsored and "BIOTRONIK Asia Pacific Pte Ltd" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bach Mai Hospital" #1 collaborator was "Bach Mai Hospital" with 3 trials as a collaborator, "ASST Santi Paolo e Carlo" with 2 trials as a collaborator, "Centro Hospitalar Lisboa Ocidental" with 2 trials as a collaborator, "Heinrich-Heine University, Duesseldorf" with 2 trials as a collaborator and "Hospital Regional de Alta Especialidad "Dr. Juan Graham Casasus"" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Bach Mai Hospital" are "COVID-19" (2 trials), "Influenza A" (2 trials), "AIDS" (1 trials), "Caloric Deficit" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Bach Mai Hospital" in a lesser frequency.

Most popular intervention types in "Bach Mai Hospital" are "Drug" (9 trials), "Other" (6 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Avastin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bach Mai Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Bach Mai Hospital". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Bach Mai Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bach Mai Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".